Iranian Journal of Reproductive Medicine
Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences of Yazd
Vol. 7, No. 1, 2009, pp. 1-5
Bioline Code: rm09001
Full paper language: English
Document type: Research Article
Document available free of charge
Iranian Journal of Reproductive Medicine, Vol. 7, No. 1, 2009, pp. 1-5
© Copyright 2009 - Iranian Journal of Reproductive Medicine
The outcome of in vitro fertilization / intracytoplasmic sperm injection in endometriosis–associated and tubal factor infertility|
Nejad, Ensieh Shahrokh Tehrani; Rashidi, Batool Hosein; Larti, Atefeh; Ezabadi, Zahra; Jahangiri, Nadia & Nekoo, Elham Azimi
Endometriosis is one of the most challenging diseases that constitute 20% - 40% of women searching for their infertility diagnosis.
This study was undertaken in order to compare the outcome of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) in women with endometriosis, and tubal factor infertility as controls.
Materials and Methods:
From 2005 to 2006 a retrospective study was carried out in patients with endometriosis (n=80) and tubal infertility (n=57) after treatment with IVF/ICSI. The main outcome measures were ovarian responsiveness, quality of oocytes, implantation, pregnancy and ongoing pregnancy rates. Appropriate statistical analysis was performed using χ2 and student t-tests.
No differences were found in mean number of ampoules of hMG, duration of hMG injection, number of MΙΙ oocytes, number of embryo transferred, and rates of implantation, pregnancy, ongoing pregnancy and twin birth between women with endometriosis and tubal infertility and also between women with stages I/II or those with stages III/IV disease with women with tubal factor infertility.
Our results suggest that endometriosis does not seem to have adverse effect on outcome of IVF/ ICSI as compared with tubal infertility.
Endometriosis, IVF / ICSI outcome, Tubal factor, Infertility
Alternative site location: http://www.ijrm.ir